The University of Chicago Header Logo

Connection

Jonathan Chung to Carcinoma, Non-Small-Cell Lung

Back to Details
This is a "connection" page, showing publications Jonathan Chung has written about Carcinoma, Non-Small-Cell Lung.
Jonathan Chung
Connection Strength
0.755
Carcinoma, Non-Small-Cell Lung
  1. Retrospective analysis of real-world data to determine clinical outcomes of patients with advanced non-small cell lung cancer following cell-free circulating tumor DNA genomic profiling. Lung Cancer. 2020 10; 148:69-78.
    View in: PubMed
    Score: 0.380
  2. The Pan-Tumor Landscape of Targetable Kinase Fusions in Circulating Tumor DNA. Clin Cancer Res. 2022 02 15; 28(4):728-737.
    View in: PubMed
    Score: 0.106
  3. Hybrid Capture-Based Genomic Profiling of Circulating Tumor DNA from Patients with Advanced Non-Small Cell Lung Cancer. J Thorac Oncol. 2019 02; 14(2):255-264.
    View in: PubMed
    Score: 0.084
  4. HER2 Transmembrane Domain (TMD) Mutations (V659/G660) That Stabilize Homo- and Heterodimerization Are Rare Oncogenic Drivers in Lung Adenocarcinoma That Respond to Afatinib. J Thorac Oncol. 2017 03; 12(3):446-457.
    View in: PubMed
    Score: 0.074
  5. Reply: To PMID 22733932. AJR Am J Roentgenol. 2013 May; 200(5):W541.
    View in: PubMed
    Score: 0.057
  6. Mediastinal lymph node staging: from noninvasive to surgical. AJR Am J Roentgenol. 2012 Jul; 199(1):W54-64.
    View in: PubMed
    Score: 0.054
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.